β2-Adrenergic Receptor Agonists in Diabetic Kidney Disease: Exploring a New Frontier
Diabetic kidney disease is a major cause of end-stage kidney disease. Various metabolic, hemodynamic, inflammatory, and profibrotic factors secondary to diabetes mellitus result in complex intracellular signaling, which in turn is responsible for the functional and structural changes associated with...
Saved in:
| Main Authors: | Shreya Hegde, Bharti Chogtu, Rahul Magazine, Ravindra Prabhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Biochemistry Research International |
| Online Access: | http://dx.doi.org/10.1155/bri/5428052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinson’s Disease
by: Lynda Peterson, et al.
Published: (2014-01-01) -
Molecular simulations reveal intricate coupling between agonist-bound β-adrenergic receptors and G protein
by: Yanxiao Han, et al.
Published: (2025-02-01) -
New Aspects of 2-Adrenergic Agonists
by: Touseef Sayyar
Published: (2015-12-01) -
Predicting novel binding modes of agonists to β adrenergic receptors using all-atom molecular dynamics simulations.
by: Stefano Vanni, et al.
Published: (2011-01-01) -
Expert consensus document on β-adrenergic receptor blockers
by: article Editorial
Published: (2005-02-01)